![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/05/2908872/0/en/Medsenic-subsidiary-of-BioSenic-SA-extends-key-patent-to-the-United-States.html
https://www.globenewswire.com/news-release/2024/07/02/2907129/0/en/Medsenic-BioSenic-s-subsidiary-signed-a-new-set-of-licensing-and-commercialization-agreements-with-Phebra-PTY-Ltd.html
https://www.pharmaceutical-technology.com/news/medsenic-licence-phebra-oato/
https://www.globenewswire.com/news-release/2023/02/08/2603612/0/en/BioSenic-announces-the-approval-and-publication-of-the-Prospectus-for-listing-and-admission-to-trading-of-the-shares-and-subscription-rights-issued-in-the-context-of-the-capital-in.html
https://www.fiercebiotech.com/biotech/complex-fracturing-bone-brings-together-inflammatory-orthopedic-biotechs-reverse-merger
https://www.globenewswire.com/news-release/2022/08/09/2495417/0/en/Bone-Therapeutics-to-broaden-and-derisk-therapeutic-portfolio-by-acquiring-majority-participation-in-Medsenic.html